• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors

tetano

Editor, Senior Moderator
Int J Comput Biol Drug Des. 2015;8(1):1-18. doi: 10.1504/IJCBDD.2015.068753. Epub 2015 Apr 13.
[h=1]Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.[/h] Singh KhD[SUP]1[/SUP], Kirubakaran P[SUP]1[/SUP], Nagamani S[SUP]1[/SUP], Karthikeyan M[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The main goal of this study is to understand the molecular-level interactions of neuraminidase inhibitor. The molecular docking, molecular dynamics and binding energy calculation analyses were carried out and the results revealed that the 150-cavitiy in the active site may play an important role in binding of drugs. Free energy calculations revealed that electrostatic interaction is more favourable for Oseltamivir interaction with H1N1 and van der Waals interaction is more favourable for H5N1, whereas Zanamivir favours the electrostatic interaction in both the strains (H1N1 and H5N1). Energy-optimised pharmacophore mapping was created using Oseltamivir drug. The pharmacophore model contained two hydrogen-bond acceptor and two hydrogen bond donor sites. Using these pharmacophore features, we screened a compound database to find a potential ligand that could inhibit the H1N1 protein. The current research will pave the way to find potent neuraminidase inhibitors against H1N1 (2009) strain.


PMID: 25869316 [PubMed - in process]
 
Back
Top Bottom